JICA Scientific Meeting
10 August 2022, Sukosol Hotel

JICA Scientific Meeting
For
Research on SARS-CoV-2 response to effective detection,
discovery and production of biotherapeutic against SARS-CoV-2
and other viral pathogens

Organized by
Bamrasnaradura Infectious Diseases Institute (BIDI)
Faculty of Tropical Medicine, Mahidol University (FTM, MU)
Department of Medical Sciences, Ministry of Public Health (DMSc, MOPH)

In collaboration with
Research Institute for Microbial Diseases, Osaka University (RIMD, OU)
International Center for Biotechnology, Osaka University (ICB, OU)
Faculty of Pharmaceutical Sciences, Chulalongkorn University (FPS, CU)
Faculty of Medicine, King Mongkut’s Institute of Technology, Ladkrabang (FM,KMITL)JICA Scientific Meeting
10 August 2022, Sukosol Hotel

Wednesday 10th August 2022
Sukosol Hotel, Bangkok, Thailand

Program
8.30 – 8.50

Registration

8.50 – 9:00

JICA Global Health and Medicine (VDO)

9.00 - 9.15

Opening Remark- Mr. Morita Takahiro Chief Representative JICA Thailand office- Assoc. Prof. Dr. Weerapong Phumratanaprapin Dean; Faculty of TropicalMedicine, Mahidol University (VDO)- Dr. Kitpong Sunchatawirul, Director; Bamrasnaradura Infectious Diseases
Institute, Department of Disease control, Ministry of Public Health- Prof. Dr. Tatsuo Shioda; Research Institute for Microbial Diseases (RIMD),
Osaka University, Osaka, Japan

9.15-9.20

JICA supported projects at Faculty of Tropical Medicine 2009-2022, Reported
by Assoc. Prof. Dr. Pongrama Ramasoota (FTM, MU)

9.20-9.25

Group Photo

Session 1;

SAR-CoV-2 at BIDI

Chair persons; Prof. Shioda, Dr. Pongrama
9.25-9.45

Visal Moolasart (BIDI)

Abstract 1.1

COVID-19 in Bamrasnaradura Infectious Diseases Institute (BIDI), Pediatrician’sexperiences
9.45-10.05

Sumonmal Uttayamakul (BIDI)

Abstract 1.2Capacity building for SAR-CoV-2 genomic variants detection in BIDI
10.05-10.20

Coffee breakJICA Scientific Meeting
10 August 2022, Sukosol HotelSession 2;

HuMAb production and characterization against SAR-CoV-2

Chair persons; Prof. Shioda, Dr. Pongrama
10.20 -10.40 Waranyoo Phoolcharoen (FPS, CU)

Abstract 2.1

Plant-produced SARS-Cov2 Monoclonal antibodies
10.40 -11.00 Panadda Dhepakson (Medical Life Sciences Institute, DMSc)

Abstract 2.2

Development of recombinant human monoclonal antibodies with pan-neutralizing
activities against SARS-CoV-2 variants and Establishment of a protein- basedsurrogate and pseudotype virus neutralization assay for SARS-CoV-2
11.00 -11.20 Surachet Benjathummarak (FTM-MU) (Online)

Abstract 2.3

Generation of a single-chain fragment variable (scFv) antibody against SARSCoV-2 RBD protein using convalescent patients-derived phage display libraries(FTM-MU)
11:20-11:40 Tadahiro Sasaki (RIMD, Osaka University)

Abstract 2.4

Anti-nucleocapsid antibodies may be related to the severity of COVID-19
11.40–12.00 Atsushi Yamanaka (RIMD, Osaka University)

Abstract 2.5

Antibody Dependent Enhancement (ADE) of SARS-CoV-2 infection
12:00-13:00 Lunch

Session 3:

HuMAb production and characterization against dengue virus

Chair persons; Dr. Yamanaka, Dr. Pongrama

13.00–13.20

Pongrama Ramasoota (FTM-MU)

Abstract 3.1

Therapeutic human monoclonal antibody against dengue virus; towardcommercialization
13.20 -13.40 Subenya Injampa (Faculty of Medicine, KMITL)

Abstract 3.2

Characterization of Fc modification of anti-Envelope human monoclonal
antibodies against dengue virus
13.40 -14.00 Pannamthip Pitaksajjakul (FTM-MU)

Abstract 3.3

Potential dengue therapeutic candidates based on dengue NS1 protein

JICA Scientific Meeting
10 August 2022, Sukosol HotelSession 4:

Biotherapeutics discovery and production

Chair persons; Dr. Sasaki, Dr. Pongrama
14.00-14.20

Charin Thawornkuno (FTM-MU)

Abstract 4.1

Egg laying hen: a promising platform for therapeutic antibody production
14.20 -14.40

Ryo Misaki (ICB, OU) (Online)

No Abstract

New technology for biotherapeutic production
14.40 -15.00 Kazuhito Fujiyama (ICB, OU) (Online)

No Abstract

Biotherapeutic production in plant
15.00 -15.20 Dr. Xin Liu (Sphere fluidic Co. Ltd.) (Online)
Abstract 4.2
CYTO-MINE® And Novel Bioassays Accelerating Biotherapeutics Discovery
And Development
15.20-15.35

Coffee break

15.35 -16.00 Discussion for future research collaboration on Biologics development

16.00-16.10

Conclusion and closing remarks

Registration:ลงทะเบียนยืนยันเข้าร่ วมการประชุม ณ โรงแรมสุ โกศลได้ที่ https://forms.gle/KdmXkmM6bnLRw5Xq5หรื อ สแกน Qr CodeLanguage: English